Receptor Signaling Bias: A Valuable and Accessible Property of New Drug

Live with Dr. Terry Kenakin (UNC Chapel Hill). The biological basis of receptor signaling bias, how to detect and quantify it, and how these data guide lead selection in GPCR drug discovery. In collaboration with Eurofins DiscoverX. Free registration. Recording available afterward.